Skip to main navigation
Logo

Quarterly Results

Quarterly Results

Show all

2022

Q4
  • Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
  • Form 10-K
Q3
  • Earnings Release
  • Form 10-Q
Q2
  • Earnings Release
  • Form 10-Q
Q1
  • Earnings Release
  • Form 10-Q

2021

Q4
  • Earnings Release
  • Form 10-K
Q3
  • Earnings Release
  • Form 10-Q
Q2
  • Earnings Release
  • Form 10-Q

 

 


Toolkit

Print Page

Email Alerts

RSS Feeds

Investor Contact

Main Menu

  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR
  • More
    • About
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Collaborations
      • Licenses
    • Technology
      • chRDNAs
      • Allogeneic T cells
      • Allogeneic NK cells
      • Scientific Publications
    • Pipeline
      • T cell pipeline
      • NK cell pipeline
      • AbbVie programs
      • Clinical trials
    • Careers
      • Job Opportunities
      • Values
      • Spotlights
      • Benefits
        • Summary of Benefits
    • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Leadership
        • Board of Directors
        • Committee Composition
      • Financials & Filings
        • SEC Filings
        • Annual Reports
        • Quarterly Results
      • IR Resources
        • FAQs
        • Email Alerts
        • Contact IR
    • Contact

    Main Menu

    • About
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Collaborations
      • Licenses
    • Technology
      • chRDNAs
      • Allogeneic T cells
      • Allogeneic NK cells
      • Scientific Publications
    • Pipeline
      • T cell pipeline
      • NK cell pipeline
      • AbbVie programs
      • Clinical trials
    • Careers
      • Job Opportunities
      • Values
      • Spotlights
      • Benefits
        • Summary of Benefits
    • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Leadership
        • Board of Directors
        • Committee Composition
      • Financials & Filings
        • SEC Filings
        • Annual Reports
        • Quarterly Results
      • IR Resources
        • FAQs
        • Email Alerts
        • Contact IR
    • Contact

    logo

    Caribou Biosciences, Inc.
    2929 7th Street, Suite 105
    Berkeley, CA 94710
    Tel: 510-982-6030
    info@cariboubio.com

    ©  Caribou Biosciences, Inc. All rights reserved.

    02. Footer Copyright Links

    • Privacy Policy
    • Terms of Use

    03. Footer Social Links

    • Twitter
    • linkedin